Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne.
Burnet Institute, Melbourne.
J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.
Older adults are at high risk of influenza disease, but generally respond poorly to vaccination. Antibody-dependent cellular cytotoxicity (ADCC) may be an important component of protection against influenza infection. An improved understanding of the ADCC response to influenza vaccination in older adults is required.
We studied sera samples from 3 groups of subjects aged ≥65 years (n = 16-17/group) receiving the 2008/2009 seasonal trivalent influenza vaccine (TIV). Subjects had minimal pre-existing hemagglutination inhibiting (HAI) antibodies and TIV induced either no, low, or high HAI responses. Serum ADCC activity was analyzed using Fc receptor cross-linking, NK cell activation, and influenza-infected cell killing.
Most subjects from TIV nonresponder, low responder, and high responder groups had detectable ADCC antibodies prevaccination, but baseline ADCC was not predictive of HAI vaccine responsiveness. Interestingly, ADCC and HAI responses tracked closely across all groups, against all 3 TIV hemagglutinins, and in all ADCC assays tested.
Older adults commonly have pre-existing ADCC antibodies in the absence of high HAI titers to circulating influenza strains. In older vaccinees, ADCC response mirrored HAI antibodies and was readily detectable despite high postvaccination HAI titers. Alternate measures of vaccine responsiveness and improved vaccinations in this at-risk group are needed.
老年人患流感的风险很高,但通常对疫苗接种的反应不佳。抗体依赖性细胞细胞毒性(ADCC)可能是预防流感感染的重要组成部分。需要更好地了解老年人对流感疫苗接种的 ADCC 反应。
我们研究了 3 组年龄≥65 岁的受试者(每组 16-17 人)的血清样本,他们接受了 2008/2009 季节性三价流感疫苗(TIV)。受试者的预先存在的血凝抑制(HAI)抗体很少,TIV 诱导的 HAI 反应要么没有,要么低,要么高。使用 Fc 受体交联、NK 细胞激活和流感感染细胞杀伤来分析血清 ADCC 活性。
TIV 无反应者、低反应者和高反应者组的大多数受试者在接种疫苗前都可检测到 ADCC 抗体,但基线 ADCC 并不能预测 HAI 疫苗反应性。有趣的是,ADCC 和 HAI 反应在所有组中都密切相关,针对所有 3 种 TIV 血凝素,并且在所有测试的 ADCC 测定中都如此。
在没有针对循环流感株的高 HAI 滴度的情况下,老年人通常具有预先存在的 ADCC 抗体。在老年疫苗接种者中,ADCC 反应与 HAI 抗体相似,尽管在接种疫苗后 HAI 滴度很高,但仍能轻易检测到。在这个高风险人群中,需要替代疫苗反应性的衡量标准和改进的疫苗接种。